Clinical Trials Browser

Phase 2/3 × Pancreatic Neoplasms × 130-nm albumin-bound paclitaxel × Clear all

NCT06361888 2025-12-30

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

Phase 2/3 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05254171 2024-11-06

ASPIRE

Phase 2/3 Recruiting

Gastrointestinal

Pancreatic Neoplasms